Neurogene
NGNE
NGNE
22 hedge funds and large institutions have $31.2M invested in Neurogene in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$379K | |
| 2 | +$376K | |
| 3 | +$350K | |
| 4 |
BC
Broadfin Capital
New York
|
+$159K |
| 5 |
SIM
Spark Investment Management
New York
|
+$86K |
Top Sellers
| 1 | -$677K | |
| 2 | -$169K | |
| 3 | -$144K | |
| 4 |
Jane Street
New York
|
-$133K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$28.2K |